PSA testing and digital rectal examination in New Zealand

Australian and New Zealand Journal of Public Health

Volumn 27, Issue 5, 2003, Pages 502-506

  Sneyd, Mary Jane ^a   Cox, Brian ^a   Paul, Charlotte ^a   Skegg, David C G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PROSTATE CANCER; PROSTATE DISEASE; PUBLIC HEALTH; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECTUM; SOCIAL STATUS; TELEPHONE;

EID: 0142060961     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2003.tb00822.x     Document Type: Article

References (30)

1. Grossfeld G, Carroll P. Prostate cancer early detection: A clinical perspective. Epidemiol Rev 2001;23(1):173-80.
2. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: A decade of discovery - What we have learned and where we are going. J Urol 1999;162:293-306.
3. Chapple A, Ziebland S, Shepperd S, Miller R, et al. Why men with prostate cancer want wider access to prostate specific antigen testing: Qualitative study. Br Med J 2002;325:737-41.
4. Donovan J, Frankel S, Neal D, Hamdy F. Screening for prostate cancer in the UK: Seems to be creeping in by the back door. Br Med J 2001;323:763-4.
5. Lefevre M. Prostate cancer screening: More harm than good? Am Fam Physician 1998;58(2):432-7.
6. Neal D, Leung H, Powell P, Hamdy F, et al. Unanswered questions in screening for prostate cancer. Eur J Cancer 2000;36:1316-21.
7. Cancer Society. Screening for cancer of the prostate [pdf]. Auckland, NZ: Cancer Society of New Zealand; 1999 November Available from: http://www.cancernz.org.nz [cited 2002 September].
8. National Health Committee. Screening for Prostate Cancer. Wellington, NZ: New Zealand National Health Committee; 1996.
9. New Zealand Health Information Service. Health statistics: Cancer statistics 1999 [online]. Wellington, NZ: Ministry of Health; 2002 December 1. Available from: http://www.nzhis.govt.nz/stats/cancerstats.htm1#selectedsites [cited 2003 June 6].
10. Cox B. Prostate cancer screening is experimental. N Z Med J 1996;109(1017):63-4.
11. Cox B, Sneyd M, Paul C, Delahunt B, et al. Vasectomy and risk of prostate cancer. J Am Med Assoc 2002;287(23):3110-5.
12. Election Enrolment Centre. Enrolment statistics [online]. Wellington, NZ: Elections New Zealand; 2002 July 29. Available from: http://www.elections.govt.nz/elections.pandr/ages.html [cited 2002 August 1].
13. 1996 Census of Population and Dwellings: Education. Wellington, NZ: Statistics New Zealand; 1998.
14. New Zealand Standard Classification of Occupations, 1987. Wellington, NZ: Statistics New Zealand; 1987.
15. Elley W, Irving J. The Elley-Irving socio-economic index: 1981 census revision. N Z J Educ Stud 1985;20(2):115-28.
16. The health and disability sector. In: Healthy New Zealanders Briefing Papers for the Minister of Health 1996, vol. 2. Wellington, NZ: Ministry of Health; 1996. p. 50-5.
17. Smith PG. Comparison between registries: Age-standardized rates. In: Parkin D, Muir C, Whelan S, Gao Y-T, et al., editors. Cancer Incidence in Five Continents. Lyon: IARC Scientific Publications; 1992. p. 865-70.
18. Weller D, Pinnock C, Silagy C, Hiller JE, et al. Prostate cancer testing in SA men: Influence of sociodemographic factors, health beliefs and LUTS. Aust N Z J Public Health 1998;22:400-2.
19. Määttänen L, Auvinen A, Stenman U-H, Tammela T, et al. Three-year results of the Finnish prostate cancer screening trial. J Natl Cancer Inst 2001;93(7):522.
20. Morris J, McNoe B. Screening for prostate cancer: What do general practitioners think? N Z Med J 1997;110:178-82.
21. Australian Health Technology Advisory Committee. Prostate cancer screening [online]. Canberra, ACT: Commonwealth Department of Health and Family Services; 2001 November 28. Available from: http://www.health.gov.au:80/hfs/pubs/ahtac/prostate.htm [cited 2002 October 23].
22. McCredie M, Coates M, Churches T, Rogers J. Rising incidence of prostate cancer in Australia: A result of 'screening'? J Epidemiol Biostat 1996;1(2):99-105.
23. Pinnock CB, Weller DP, Marshall VR. Self-reported prevalence of prostate-specific antigen testing in South Australia: A community study. Med J Aust 1998;169:25-8.
24. Slevin T, Donnelly N, Clarkson J, English D, et al. Prostate cancer testing: Behaviour, motivation and attitudes among Western Australian men. Med J Aust 1999;171(4):185-8.
25. Centre for Reviews and Dissemination. Screening for Prostate Cancer: Effectiveness Matters. London: National Health Service; 1997.
26. UK National Screening Committee. Second Report of the UK National Screening Committee. London: Department of Health, Social Services and Public Safety; 2001. p. 20.
27. Brewster D, Fraser L, Harris V, Black R. Rising incidence of prostate cancer in Scotland: Increased risk or increased detection? BJU Int 2000;85:463-73.
28. Threlfall TJ, English DR, Rouse IL. Prostate cancer in Western Australia: Trends in incidence and mortality from 1985 to 1996. Med J Aust 1998;169:21-4.
29. Ward J, Hughes A-M, Hirst G, Winchester L. Men's estimates of prostate cancer risk and self-reported rates of screening. Med J Aust 1997;167:250-3.
30. Ferrini R, Woolf S. Screening for Prostate Cancer in American Men. Washington, DC: American College of Preventive Medicine; 2001. p. 1-4.